Affiliation:
1. Molecular Internal Medicine, University of Zürich, Zürich, Switzerland
2. Division of Surgery and Interventional Science, University College London, London, United Kingdom
Abstract
On March 4, 2017 at the age of 68, Sidney George Shaw (Sid) unexpectedly died from complications following surgery, only four years after retiring from the University of Bern. Trained in biochemistry at Oxford University, Sid had quickly moved into molecular pharmacology and became a key investigator in the field of enzyme biochemistry, vasoactive peptide research, and receptor signaling. Sid spent half his life in Switzerland, after moving to the University of Bern in 1984. This article, written by his friends and colleagues who knew him and worked with him during different stages of his career, summarizes his life, his passions, and his achievements in biomedical research. It also includes personal memories relating to a dear friend and outstanding scientist whose intellectual curiosity, humility, and honesty will remain an example to us all.
Publisher
Institute of Physiology of the Czech Academy of Sciences
Subject
General Medicine,Physiology
Reference45 articles.
1. ABRAHAM D, HANDLER C, DASHWOOD MR, COGHLAN G (eds): Translational Vascular Medicine. Pathogenesis, Diagnosis, and Treatment. Springer, London, 2012, pp 1-268.
2. BALSIGER B, RICKENBACHER A, BODEN PJ, BIECKER E, TSUI J, DASHWOOD M, REICHEN J, SHAW SG: Endothelin A-receptor blockade in experimental diabetes improves glucose balance and gastrointestinal function. Clin Sci (Lond) 103 (Suppl 48): 430S-433S, 2002.
3. BARTON M (ed.): Endothelin XII - Proceedings of the Twelfth International Conference on Endothelin, Clare College, University of Cambridge, United Kingdom, September 11-14, 2011. Life Sci 91: 449-750, 2012.
4. BARTON M, SHAW S, D'USCIO LV, MOREAU P, LUSCHER TF: Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 238: 861-865, 1997.
5. BARTON M, HAUDENSCHILD CC, D'USCIO LV, SHAW S, MÜNTER K, LUSCHER TF: Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 95: 14367-14372, 1998.